Implications and results of the Diabetes Control and Complications Trial (Q41455224)

30 September 2017

1 reference

title

Implications and results of the Diabetes Control and Complications Trial (English)

1 reference

30 September 2017

Tamborlane WV

1

1 reference

PubMed ID

9130921

30 September 2017

Ahern J

series ordinal

2

1 reference

30 September 2017

1 April 1997

1 reference

Pediatric Clinics of North America

30 September 2017

1 reference

30 September 2017

44

1 reference

30 September 2017

285-300

1 reference

30 September 2017

2

1 reference

Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Implications of the Diabetes Control and Complications Trial. American Diabetes Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Expanded role of the dietitian in the Diabetes Control and Complications Trial: implications for clinical practice. The DCCT Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Implementation of treatment protocols in the Diabetes Control and Complications Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Resource utilization and costs of care in the diabetes control and complications trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Reviewing the Diabetes Control and Complications Trial: one member of the "control panel" speaks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

The Natural History of Retinopathy in Insulin-Dependent Juvenile-Onset Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Long-term continuous subcutaneous insulin infusion in diabetics at home

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Improved insulin sensitivity in patients with type I diabetes mellitus after CSII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Diabetes control and complications: New strategies and insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

Patient self-monitoring of blood glucose and refinements of conventional insulin treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970477-6

10.1016/S0031-3955(05)70477-6

7 January 2021

Identifiers

DOI

1 reference

release_7wdkwalgovb7bg3yuu4sg3rm6q

30 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7wdkwalgovb7bg3yuu4sg3rm6q

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9130921

1 reference

PubMed ID

9130921